Biomolecular-chemical screening. A novel screening approach for the discovery of biologically active secondary metabolites. II. Application studies with pure metabolites

Journal of Antibiotics

Volumn 52, Issue 11, 1999, Pages 952-959

  Maier, Armin ^a   Maul, Corinna ^a   Zerlin, Marion ^a   Grabley, Susanne ^a   Thiericke, Ralf ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALICINE; ALICYCLIC COMPOUND; ALIPHATIC COMPOUND; ALKALOID; AMINO ACID; ANISOLE DERIVATIVE; AROMATIC COMPOUND; CARBOHYDRATE DERIVATIVE; CEPHALOTAXINE; CHELERYTHRINE; CYCLOSERINE; DRUG; FURANONE DERIVATIVE; HETEROCYCLIC COMPOUND; IVERMECTIN; LACTONE DERIVATIVE; MACROLIDE; MEGALOMICIN; NATURAL PRODUCT; NOVOBIOCIN; PEPTIDE DERIVATIVE; POLYETHER DERIVATIVE; QUEBRACHAMINE; QUINONE DERIVATIVE; RUTAMYCIN; SANGUINARINE; TETRANDRINE; TRIOXYSALEN; UNINDEXED DRUG; YOHIMBINE DERIVATIVE;

ARTICLE; DRUG BINDING; DRUG DNA BINDING; DRUG SCREENING; MACROMOLECULE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

EID: 0032785929     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.952     Document Type: Article

References (44)

1. VERPOORTE, R.: Exploration of nature's chemodiversity: The role of secondary metabolites as leads in drug development. Drug Discovery Today 3: 232-238, 1998
2. CRAGG, G. M.; D. J. NEWMAN & K. M. SNADER: Natural products in drug discovery and development. J. Nat. Prod. 60: 52-60, 1997
3. WILSON, W. D.; S. MIZAN, F. A. TANIOUS, S. YAO & G. ZON: The interaction of intercalators and groove-binding agents with DNA triple-helical structures: The influence of ligand structure, DNA backbone modifications and sequence. J. Mol. Recognit. 7: 89-98, 1994
4. MAIER, A.; C. MAUL, M. ZERLIN, I. SATTLER, S. GRABLEY & R. THIERICKE: Biomolecular-chemical screening. A novel screening approach for the discovery of biologically active secondary metabolites. I. Screening strategy and validation. J. Antibiotics 52: 945-951, 1999
5. BERDY, J. E.; A. ASZALOS, M. BOSTIAN & K. L. MCNITT: Handbook of antibiotic compounds, Vol. I-XIV CRC Press, Florida, 1987
6. YOUNG, Y. & D. J. GAMES: Supercritical fluid chromatography of Fusarium mycotoxins. J. Chromatogr. 627: 247-254, 1992
7. HUANG, M. T: Harringtonine, an inhibitor of initiation of protein biosynthesis. Mol. Pharmacol. 11: 511-519, 1975
8. HERBERT, J. M.; J. M. AUGEREAU, J. GLEYE & J. P. MAFFRAND: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:993-999, 1990
9. BAJAJ, N. P.; M. J. MCLEAN, M. J. WARING & E. SMEKAL: Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. J. Mol. Recognit. 3: 48-54, 1990
10. VAN BEEK, T. A.; R. VERPOORTE, A. B. SVENDSEN & R. FOKKENS: Antimicrobially active alkaloids from Tabernaemontana chippii. J. Nat. Prod. 48: 400-423, 1985
11. KAMARAJAN, P.; N. SEKAR, V. MATHURAM & S. GOVINDASAMY: Antitumor effect of echitamine chloride on methylcholonthrene induced fibrosarcoma in rats. Biochem. Int. 25: 491-498, 1991
12. DEUTSCH, H. F.; M. A. EVENSON, P. DRESCHER, C. SPARWASSER & P. O. MADSEN: Isolation and biological activity of aspidospermine and quebrachamine from an aspidosperma tree source. J. Pharm. Biomed. Anal. 12: 1283-1287, 1994
13. BLAXALL, H. S.; T. J. MURPHY, J. C. BAKER, C. RAY & D. B. BYLUND: Characterization of the α-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther. 259: 323-329, 1991
14. SIMANEK, V.: Benzophenanthridine alkaloids. The Alkaloids 26: 185-240, 1985
15. + channels. Life Sciences 56: 295-306, 1995
16. FRIEDMAN, M.; P. R. HENIKA & B. E. MACKEY: Feeding of potato, tomato and eggplant alkaloids affects food consumption and body and liver weights in mice. J. Nutr. 126:989-999, 1996
17. GRABLEY, S.; E. GRANZER, K. HUTTER, D. LUDWIG, M. MAYER, R. THIERICKE, G. TILL, J. WINK, S. PHILIPPS & A. ZEECK: Secondary metabolites by chemical screening: 8. Decarestrictines, a new family of inhibitors of cholesterol biosynthesis from Penicillium. 1. Strain description, fermentation, isolation, properties. J. Antibiotics 45: 56-65, 1992
18. SAKURAI, K.; H. MATSUMOTO & J. ADACHI: Antifungal studies on drugs. I. Antifungal activity of five-membered lactone derivatives. Yakugaku Zasshi 88: 919-928, 1968
19. AHMAD, S. I.: A mutant of Escherichia coli hyper-resistant to a number of DNA-damaging agents: location of the mutational site. J. Photochem. Photobiol. B. 36: 47-53, 1996
20. GENCHEVA, M.; B. ANACHKOVA & G. RUSSEV: Mapping the sites of initiation of DNA replication in rat and human rRNA genes. J. Biol. Chem. 271: 2608-2614, 1996
21. KAWASHIMA, A.; Y. NAKAMURA, Y. OHTA, T. AKAMA, M. YAMAGISHI & K. HANADA: New cholesterol biosynthesis inhibitors MC-031 (O-demethylchlorothricin), -032 (O-demethylhydroxychlorothricin), -033 and -034. J. Antibiotics 45: 207-212, 1992
22. DIDIER, A. & F. LOOR: The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 7: 745-751, 1996
23. BONAY, P.; S. MUNRO, M. FRESNO & B. ALARCON: Intragolgi transport inhibition by megalomicin. J. Biol. Chem. 271:3719-3726, 1996
24. TONSGARD, J. H.; B. TUNG, K. S. KORNAFEL & G. S. GETZ: Environmentally induced differential amplification of mitochondrial populations. Biochem. J. 270: 511-518, 1990
25. HOTTA, K.; C. B. ZHU, P. PHOMSUWANSIRI, J. ISHIKAWA, S. MIZUNO, M. HATSU & S. IMAI: PCR inhibition assay for DNA-targeted antibiotics. J. Antibiotics 48: 1267-1272, 1995
26. SHINOMIYA, M.; W. CHU, R. G. CARLSON, R. F. WEAVER & F. TAKUSAGAWA: Structural, physical, and biological characteristics of RNA·DNA binding agent N8-actinomycin D. Biochemistry 34: 8481-8491, 1995
27. LAWRENCE, D. A.; R. SONG & P. WEBER: Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J. Leukoc. Biol. 60: 611-618, 1996
28. TUITE, E.; U. SEHLSTEDT, P. HAGMAR, B. NORDEN & M. TAKAHASHI: Effects of minor and major groove-binding drugs and intercalators on the DNA association of minor groove-binding proteins RecA and deoxyribonuclease I detected by flow linear dichroism. Eur. J. Biochem. 243: 482-492, 1997
29. MOORE, C. W.: Cleavage of cellular and extracellular Saccharomyces cerevisiae DNA by bleomycin and phleomycin. Cancer Res. 49: 6935-6940, 1989
30. LIU, H. L.; H. M. LU, D. G. LI, F. QI & Z. M. JIANG: Effects of egtazic acid and calcimycin on synthesis of DNA and collagen in cultured human lung fibroblasts. Chung Kuo Yao Li Hsueh Pao 17: 63-65, 1996
31. NAKAMURA, M.; S. KUNIMOTO, Y. TAKAHASHI, H. NAGANAWA, M. SAKAUE, S. INOUE, T. OHNO & T. TAKEUCHI: Inhibitory effects of polyethers on human immunodeficiency virus replication. Antimicrob. Agents Chemother. 36: 492-494, 1992
32. IRURZUN, A.; P. S. SANCHEZ, I. NOVOA & L. CARRASCO: Monensin and nigericin prevent the inhibition of host translation by poliovirus, without affecting p220 cleavage. J. Virol. 69: 7453-7460, 1995
33. MURRAY, R. D. H. & J. A. ROBINSON: Chemical and biochemical aspects of polyether-ionophore antibiotics biosynthesis. Fortschr. Chem. Org. Naturst. 58: 1-81, 1991
34. SHELTON, C. J.; M. M. HARDING & A. S. PRAKASH: Enzymatic and chemical footprinting of anthracycline antitumor antibiotics and related saccharide side chains. Biochemistry 35: 7974-7982, 1996
35. ECKARDT, K.; D. TRESSELT, G. SCHUMANN, W. IHN & C. WAGNER: Isolation and chemical structure of aklanonic acid, an early intermediate in the biosynthesis of anthracyclines. J. Antibiotics 38: 1034-1039, 1985
36. TOBE, H.; A. YOSHIMOTO & T. ISHIKURA: New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1. J. Antibiotics 35: 1641-1645, 1982
37. WARING, M. J.: DNA modification and cancer. Ann. Rev. Biochem. 50: 159-192, 1981
38. FRITSCHE, H.; U. WAHNERT, J. B. CHAIRES, N. DATTAGUPTA, F. B. SCHLESSINGER & D. M. CROTHERS: Anthracycline antibiotics. Interaction with DNA and nucleosomes and inhibition of DNA synthesis. Biochemistry 26: 1996-2000, 1987
39. FOX, K. R. & Z. ALAM: Footprinting studies of DNA-sequence recognition by nogalamycin. Eur. J. Biochem. 209:31-36, 1992
40. BRODASKY, T. F. & S. MIZSAK: Steffimycin C, a new member of the steffimycin anthracyclines. Isolation and structural characterization. J. Antibiotics 38: 849-855, 1985
41. HASSPIELER, B. M.; G. D. HAFFNER & K. ADELI: Influence of DT diaphorase on quinone-mediated genotoxicity in human and fish cell lines. Mutat. Res. 360: 43-49, 1996
42. WACLAWSKI, A. P. & P. J. SINKO: Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations. J. Pharm. Sci. 85:478-485, 1996
43. MARUYAMA, T.; K. UTSUMI, H. TOMIOKA, M. KASAMOTO, Y. SATO, T. ANNE & E. DECLERCQ: Synthesis, antiviral, antibacterial and antitumor cell activities of 2′-deoxy-2′-fluoropuromycin. Chem. Pharm. Bull. 43: 955-959, 1995
44. PAULULAT, T.; Y.-Q. TANG, S. GRABLEY & R. THIERICKE: Combinatorial chemistry: The impact of natural products. Chimica Oggi, Chemistry Today 17: 52-56, 1999